Comparison of intravenous and oral definitive antibiotic regimens in hospitalised patients with Gram-negative bacteraemia from a urinary tract infection

医学 队列 抗生素 危险系数 内科学 回顾性队列研究 菌血症 泌尿系统 队列研究 置信区间 外科 微生物学 生物
作者
Kristina M. Thurber,Joshua R. Arnold,Prasanna P. Narayanan,Ross A. Dierkhising,Priya Sampathkumar
出处
期刊:Journal of global antimicrobial resistance [Elsevier]
卷期号:18: 243-248 被引量:11
标识
DOI:10.1016/j.jgar.2019.03.013
摘要

Transitioning patients from intravenous (IV) to oral antibiotic therapy has been shown to be a successful approach for several infections. However, minimal data exist evaluating outcomes following transition from to oral antibiotics for patients with bacteraemia secondary to a urinary tract infection (UTI). This study compared treatment failures between patients treated exclusively with IV antibiotics and those transitioned from IV to oral antibiotics for bacteraemia secondary to UTI.This single-centre, retrospective cohort study included hospitalised, non-critically ill adult patients treated with culture-susceptible antibiotic therapy for 7-21 days. Patients were divided into two cohorts based on the route of definitive antibiotic administration. Treatment failure was a composite outcome of death and recurrence of the index micro-organism within 21 days following negative blood cultures.Among the 346 patients enrolled, 82 (23.7%) were in the IV cohort and 264 (76.3%) were in the IV-to-oral cohort. A total of six treatment failures occurred; 2 (2.4%) in the IV cohort and 4 (1.5%) in the oral transition cohort (hazard ratio=0.62, 95% confidence interval 0.11-3.39; P=0.58). All failures were due to recurrence of the index organism. Secondary outcomes demonstrated a significantly higher rate of IV line-associated complications in the IV cohort (P=0.03) and a favourable hospital length of stay in the oral cohort (P<0.001). Patients transitioned from IV to oral antibiotics based on culture-susceptibility data experienced similarly low rates of treatment failure as those who received exclusive IV therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大个应助科研通管家采纳,获得10
刚刚
思源应助科研通管家采纳,获得10
刚刚
pluto应助科研通管家采纳,获得10
刚刚
ding应助科研通管家采纳,获得10
刚刚
小马甲应助科研通管家采纳,获得10
刚刚
刚刚
刚刚
1秒前
FFFFFFF应助yatou5651采纳,获得10
1秒前
1秒前
1秒前
Agernon应助正直冰露采纳,获得10
1秒前
1秒前
茕穹完成签到,获得积分10
1秒前
调研昵称发布了新的文献求助30
2秒前
毁灭世界完成签到 ,获得积分10
2秒前
见雨鱼完成签到,获得积分10
2秒前
2秒前
科研混子发布了新的文献求助10
2秒前
斯文香彤完成签到,获得积分10
2秒前
2秒前
3秒前
JamesPei应助单纯访枫采纳,获得30
3秒前
F冯完成签到,获得积分10
4秒前
4秒前
JJ完成签到,获得积分10
4秒前
二豆子0发布了新的文献求助10
4秒前
潦草发布了新的文献求助10
5秒前
sarah完成签到,获得积分10
5秒前
5秒前
凸迩丝儿完成签到 ,获得积分10
5秒前
科研通AI5应助wu采纳,获得30
5秒前
5秒前
爆米花应助艺玲采纳,获得10
6秒前
6秒前
诸葛雪兰发布了新的文献求助10
6秒前
7秒前
CC完成签到,获得积分10
7秒前
wanci应助gaos采纳,获得10
7秒前
顾矜应助四火采纳,获得10
7秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527521
求助须知:如何正确求助?哪些是违规求助? 3107606
关于积分的说明 9286171
捐赠科研通 2805329
什么是DOI,文献DOI怎么找? 1539901
邀请新用户注册赠送积分活动 716827
科研通“疑难数据库(出版商)”最低求助积分说明 709740